Compare INTZ & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTZ | GNTA |
|---|---|---|
| Founded | 1983 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.0M | 34.0M |
| IPO Year | 2020 | 2021 |
| Metric | INTZ | GNTA |
|---|---|---|
| Price | $1.20 | $1.33 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.25 | N/A |
| AVG Volume (30 Days) | ★ 109.7K | 96.3K |
| Earning Date | 11-11-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,290,000.00 | N/A |
| Revenue This Year | $35.44 | N/A |
| Revenue Next Year | $23.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 33.49 | N/A |
| 52 Week Low | $0.71 | $1.28 |
| 52 Week High | $5.20 | $10.00 |
| Indicator | INTZ | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 40.23 | 36.77 |
| Support Level | $1.14 | $1.28 |
| Resistance Level | $1.36 | $1.59 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 22.86 | 24.49 |
Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.